BYDUREON (exenatide synthetic)
Astrazeneca ab
Patent: 9,238,076
Expiration: Oct 15, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com